A CE-marked precision medicine IVD platform designed to support personalization of immunosuppressive therapy in kidney transplant patients. The test assesses how a patient’s immune cells respond to different immunosuppressive drugs, helping clinicians move beyond trial-and-error treatment selection. The opportunity may be relevant for investors and strategic partners active in diagnostics, transplantation, renal care, immunology, or value-based healthcare.
